Showing results (111-120 of 651) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|July 7, 2020
Usefulness of heart rate variability indices in assessing the risk of an unsuccessful return to work after sick leave in depressed patientsToshikazu Shinba, Keizo Murotsu, Yosuke Usui, et al.
Neuropsychopharmacology Reports|April 29, 2022
Identification of factors associated with the efficacy of atomoxetine in adult attention-deficit/hyperactivity disorderTsutomu Nagai, Tatsuya Kurihara, Hiroaki Koya, et al.
Neuropsychopharmacology Reports|May 3, 2022
Prenatal methotrexate injection increases behaviors possibly associated with depression and/or autism in rat offspring; A new animal model for mental disorder, based on folate metabolism deficit during pregnancyNaoki Amada, Yusuke Kakumoto, Takashi Futamura, et al.
Neuropsychopharmacology Reports|April 25, 2023
Characteristics of suicidal emergency room patients before and during the COVID-19 pandemic in JapanKyohei Otani, Ryohei Yoshikawa, Atsumi Naitou, et al.
Neuropsychopharmacology Reports|August 20, 2020
Absence of methamphetamine-induced conditioned place preference in weaver mutant miceYuiko Ikekubo, Soichiro Ide, Yoko Hagino, et al.
Neuropsychopharmacology Reports|April 4, 2023
Links between psychopathological symptoms and cortical thickness in men with severe alcohol use disorder: A Magnetic Resonance Imaging studyGéraldine Petit, Sophie Leclercq, Caroline Quoilin, et al.
Neuropsychopharmacology Reports|November 12, 2025
A Japanese Pregnant Woman With Treatment-Resistant Schizophrenia Who Continued Clozapine With Blood Concentration Monitoring During the Perinatal Period and Had a Healthy Baby: A Case ReportMariko Tsukiji, Kaori Yamazaki, Yusuke Nakata, et al.
Neuropsychopharmacology Reports|July 28, 2025
Unanticipated Pathological Laughter Following Atomoxetine Administration in a Child With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity DisorderAlireza Zibaee, Forouzan Elyasi, Arghavan Fariborzifar, et al.
Neuropsychopharmacology Reports|July 13, 2025
Primary Progressive Multiple Sclerosis: New Therapeutic ApproachesMorteza Rajabi, Sajjad Shafaeibajestan, Sevda Asadpour, et al.
Neuropsychopharmacology Reports|June 26, 2025
Effects of Antiepileptic Drugs, Carbamazepine and Phenytoin, on Plasma Concentrations of Clozapine and Its N-Desmethyl and N-Oxide Metabolites in Japanese Patients With SchizophreniaKazuro Ikawa, Tomoya Imura, Saori Nakamura, et al.
Pageof 66